Turn Therapeutics

Turn TherapeuticsTurn Therapeutics
Turn Therapeutics

Turn Therapeutics

A clinical-stage dermatology company developing novel therapies for inflammatory skin diseases.

DR 292019ActiveLos Angeles, USA
Rate

About

Turn Therapeutics, Inc. is a clinical-stage dermatology company focused on the development of innovative treatments for inflammatory skin conditions. The company aims to address unmet needs in the dermatology market by advancing novel therapeutic candidates through clinical trials.
Frequently asked

What does Turn Therapeutics do?

Turn Therapeutics, Inc. is a clinical-stage dermatology company focused on the development of innovative treatments for inflammatory skin conditions. The company aims to address unmet needs in the dermatology market by advancing novel therapeutic candidates through clinical trials.

What is Turn Therapeutics's revenue?

StartupHub estimates Turn Therapeutics's annual revenue at $5.2M (range $3.2M to $20.9M, 44% confidence), based on comparable companies in the sector.

What is Turn Therapeutics's valuation?

StartupHub estimates Turn Therapeutics's effective valuation at $151.1M (range $43.1M to $302.8M, 56% confidence), based on comparable companies in the sector.

How much funding has Turn Therapeutics raised?

Turn Therapeutics has raised a total of $25M in funding. The most recent round on record is Loan Facility.

Where is Turn Therapeutics headquartered?

Turn Therapeutics is headquartered in Los Angeles, California, USA.

When was Turn Therapeutics founded?

Turn Therapeutics was founded in 2019.

What industry does Turn Therapeutics operate in?

Turn Therapeutics operates in Biotechnology, Pharmaceuticals, Healthcare, Drug Discovery, Clinical Trials, Dermatology.

Comments

No comments yet. Be the first to share your take.